Hershey Trust CO Crispr Therapeutics Ag Transaction History

Hershey Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	BUY	$110.2 - $156.64 $1.02 Million - $1.45 Million	9,234 Added 37.65%	33,758 $3.78 Million
Q2 2021 Aug 11, 2021	BUY	$100.84 - $161.89 $770,921 - $1.24 Million	7,645 Added 45.29%	24,524 $3.97 Million
Q1 2021 Apr 29, 2021	BUY	$110.72 - $210.04 $1.87 Million - $3.55 Million	16,879 New	16,879 $2.06 Million
Q4 2020 Jan 21, 2021	SELL	$79.67 - $173.23 $392,374 - $853,157	-4,925 Closed	0 $0
Q3 2020 Oct 23, 2020	BUY	$78.5 - $100.64 $386,612 - $495,652	4,925 New	4,925 $412,000
Q4 2017 Jan 23, 2018	SELL	$16.95 - $23.48 $728,697 - $1.01 Million	-42,991 Closed	0 $0
Q3 2017 Oct 24, 2017	BUY	$16.75 - $20.66 $720,099 - $888,194	42,991	42,991 $768,000

488

59M

1.09M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Hershey Trust CO, based on Form 13F filings with the SEC.

Stay updated on Hershey Trust CO with notifications on news.